TelyRx to Host Second Quarter 2026 Financial Results Conference Call on Monday, August 10, 2026 at 8:30 am ET
TelyRx (TSX: TELY, OTCQX: TELYF) will host a conference call and webcast to discuss its second quarter 2026 financial results on Monday, August 10, 2026 at 8:30 a.m. ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
TelyRx (TSX: TELY, OTCQX: TELYF) will host a conference call and webcast to discuss its second quarter 2026 financial results on Monday, August 10, 2026 at 8:30 a.m. ET. The company expects to release the results by news release at approximately 7:00 a.m. ET the same day.
Investors can join via telephone using the provided North American and international dial-in numbers or access a live webcast through the specified online link, with participants asked to connect about 15 minutes early.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Clearwater, Florida--(Newsfile Corp. - July 24, 2026) - TelyRx Holdings Inc. (TSX: TELY) (OTCQX: TELYF) ("TelyRx" or the "Company"), a vertically integrated, technology-enabled healthcare and pharmacy services company, today announced it will host a conference call and webcast to discuss its second quarter 2026 financial results on Monday, August 10, 2026, at 8:30 a.m. Eastern Time (ET). The Company expects to report its second quarter 2026 financial results for the period ended June 30, 2026, via news release at approximately 7:00 am ET on Monday, August 10, 2026.
Telephone Dial-In Access Information
The Company will host a conference call to discuss its second quarter of 2026 financial results on Monday, August 10, 2026, at 8:30 a.m. Eastern Time (ET). To dial direct and enter the call through an operator, dial 1-844-763-8274 or 1-647-361-0247. The live webcast can be accessed by copying and pasting this link into a browser: https://www.gowebcasting.com/14752. Please connect approximately 15 minutes prior to the beginning of the webcast or call to ensure participation.
About TelyRx Holdings Inc.
TelyRx is a technology-enabled healthcare and pharmacy services company operating a digital pharmacy platform connecting patients with independent, state-licensed providers to access over 450 everyday medications across 48 U.S. states and territories. The company fulfills prescriptions through its licensed retail pharmacies and offers fast, convenient delivery of medications directly to patients' doors.
For additional information, visit www.telyrx.com or contact:
Neil Weber
Investor Relations
(647) 222-0574
investors@telyrx.com
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/306404
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.